Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 22, 2025 04:00 ET | Source: AKAMPION

1STBIO and LigaChemBio Announce Strategic R&D and Licensing Option Agreement

Expanded collaboration leverages complementary expertise to unlock next-generation oncology therapeuticsFocus on breakthrough ADC payloads and immuno-oncology candidates with out-licensing potential ...
April 15, 2025 03:00 ET | Source: AKAMPION

1ST Biotherapeutics Joins The Michael J. Fox Foundation’s LITE Program to Advance LRRK2-Based Parkinson’s Disease Research

Focus on the discovery of next-generation LRRK2 inhibitors to unlock novel biological mechanisms of action and advance new treatment options YONGIN, South Korea, April 15, 2025 – 1ST Biotherapeutics,...